Clinical Trial

AI Assisted Screening for VHD Using Routine Chest CT Scans

Study acronym: ARTEMIS
Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, multicenter study designed to validate a deep learning model for screening valvular heart diseases using routine, non-contrast chest computed tomography (CT) scans. The primary objective is to evaluate the model's diagnostic performance, with the sensitivity serving as the primary efficacy endpoint. Secondary endpoints will include other performance metrics such as area under the receiver operating characteristic curve (AUC), specificity, and accuracy, etc.
Protocol Amendment History 3 changes
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
critical Recruitment opened 2026-05-08
notable Trial sites expanded: 0 -> 3 locations 2026-05-08
Trial Details
NCT Number NCT07449130
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions Heart Valve Diseases
Enrollment 3,000 participants
Start Date 2026-03-02
Primary Completion 2026-11-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-12